Great Point Partners’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
|
|||||
|
2022
Q2 | $7.31M | Buy |
|
|||||
|
2018
Q2 | – | Sell |
|
|||||
|
2018
Q1 | $33.2M | Hold |
|
|||||
|
2017
Q4 | $31M | Sell |
|
|||||
|
2017
Q3 | $29.1M | Sell |
|
|||||
|
2017
Q2 | $27.6M | Buy |
|
|||||
|
2017
Q1 | $24.2M | Sell |
|
|||||
|
2016
Q4 | $29M | Buy |
|
|||||
|
2016
Q3 | $20M | Sell |
|
|||||
|
2016
Q2 | $21.4M | Buy |
|
|||||
|
2016
Q1 | $12.9M | Buy |
|
|||||
|
2015
Q1 | – | Hold |
|
|||||
|
2014
Q4 | – | Sell |
|
|||||
|
2014
Q3 | $18.2M | Sell |
|
|||||
|
2014
Q2 | $22.4M | Buy |
|
|||||
|
2014
Q1 | $9.98M | Buy |
|